Biden administration's Medicare drug price negotiations will face major tests in 2024
Publishing timestamp: 2023-12-28 09:21:02
Summary
3) The article discusses how Medicare will negotiate down drug prices in 2024, which could affect the prices seniors pay for medications by the end of the decade. It also mentions the lawsuits filed by drugmakers against the price talks and the potential outcomes of those cases. The article provides details on the negotiation process and the drugs that will be subject to negotiations. It also mentions the potential legal battle between drugmakers and the Biden administration, which could reach the Supreme Court.
Sentiment: MIXED
Tickers: JNJ, NOV.N-CH, NOVO.B-DK, BMY, AZN-GB, MRK, NVS,
Keywords: social issues, biotechnology, biotech and pharmaceuticals, bristol-myers squibb co, politics, health care industry, business, pharmaceuticals, breaking news: politics, johnson & johnson, joe biden, prescription drugs, breaking news, united states, novo nordisk a/s, merck & co inc, astrazeneca plc, novartis ag, business news,
Source: https://www.cnbc.com/2023/12/28/medicare-drug-price-negotiations-whats-ahead-in-2024.html